ON THE SAFETY OF ANTIBACTERIAL DRUGS USED IN PEDIATRICS

QR Code

ON THE SAFETY OF ANTIBACTERIAL DRUGS USED IN PEDIATRICS

The safety of application of different groups of antibacterial drugs in pediatrics among children is discussed in this article. The analysis was made of spontaneous reports in the national database for 2012, containing information about serious adverse reactions (AR) on antibiotics in the pediatric...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. R. Titova, E. Y. Pasternak, I. L. Asetskaya, S. K. Zyryanov, V. A. Polivanov, R. N. Alyautdin, B. K. Romanov
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:	Безопасность и риск фармакотерапии
Subjects:	антибактериальные препараты нежелательная реакция дети спонтанные сообщения «off-label» назначения antibacterial drugs adverse reaction children spontaneous reports «off-label» prescriptions
Online Access:	https://www.risksafety.ru/jour/article/view/11
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modern approaches to collecting and reporting information on side effects
by: K. E. Zatolochina, et al.
Published: (2018-02-01)

Social media as a source of information on drug safety and how to extract it
by: I. I. Snegireva, et al.
Published: (2018-02-01)

Problems of interchangeability of systemic interferons for treatment of multiple sclerosis
by: I. I. Snegireva, et al.
Published: (2018-02-01)

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015-10-01)

Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01)

Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
by: E. V. Каrabina, et al.
Published: (2024-12-01)

Retrospective analysis of reports on psychopharmaceuticals drugs safety to identify cases of off-label
by: E. O. Zhuravleva, et al.
Published: (2022-06-01)

Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01)

“Off-label” drugs: legal problems and socio-economic aspects of application practice
by: S. V. Russkikh, et al.
Published: (2023-08-01)

Clinical Trials in Pediatrics and Neonatology: Reasons for Ups and Downs
by: A. A. Mosikian, et al.
Published: (2016-08-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

Prescribing Drugs not in Accordance with the Official Instructions for Medical Use (Off-label), Clinical Guidelines, Standards of Medical Care and Legal Regulation in the Russian Federation. Part 2
by: A. R. Navasardyan, et al.
Published: (2021-05-01)

Off-Label Medicines Use: Complex Problem of Modern Clinical Practice
by: S. R. Gilyarevskiy
Published: (2020-05-01)

Analysis of spontaneous reports of adverse reactions, developed in the use of drugs during pregnancy
by: E. O. Zhuravleva, et al.
Published: (2018-02-01)

The prevalence and consequences of support for off-label Ozempic prescriptions
by: Timothy Callaghan, et al.

Exploration of Ethical Review Disputes and Regulatory Pathways of Off-label Drug Use
by: Xuelian TANG, et al.
Published: (2025-02-01)

Legal and Medical Aspects of Off-Label Medication Use. Point of View
by: O. V. Tsygankova, et al.
Published: (2019-03-01)

OFF-LABEL PRESCRIBING. POSSIBLE CAUSES, TYPES AND CONSEQUENCES. LEGAL REGULATION IN THE RUSSIAN FEDERATION
by: S. Yu. Martsevich, et al.
Published: (2017-11-01)

Off-Label Prescribing in Paediatric Cardiology: Regulatory Aspects and Safety Assessment by Spontaneous Reporting
by: E. O. Kochkina, et al.
Published: (2023-03-01)

A photosensitivity reaction to phenobarbital after taking ibuprofen
by: S. S. Postnikov, et al.
Published: (2018-02-01)

Unanswered Questions in Pediatric Clinical Trials: Literature Review
by: Leyla S. Namazova-Baranova, et al.
Published: (2022-03-01)

Experience of antihomotoxica in the complex treatment of acute odontogenic periostitis jaws
Published: (2020-04-01)

Identification and assessment of cases of malignant hyperthermia triggering under anaesthetic management: analysis of spontaneous reporting database
by: E. Yu. Kolesnikova, et al.
Published: (2018-02-01)

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
by: N. Yu. Velts, et al.
Published: (2018-09-01)

Control of adverse drug reactions in HIV/AIDS antiretroviral treatment with interchangeable medicines
by: M. V. Zhuravleva, et al.
Published: (2018-02-01)

Current issues related to the off-label use of drugs and their potential solutions
by: K. S. Radaeva, et al.
Published: (2024-04-01)

Safety of Antibacterial and Antiprotozoal Medicinal Products
by: E. V. Shubnikova, et al.
Published: (2022-07-01)

«Propofol infusion syndrome» - case in a child of 10 years
by: S. S. Postnikov, et al.
Published: (2018-02-01)

Off-label use of recombinant factor VIIa for neonatal pulmonary hemorrhage; a single-center experience
by: Özge Serçe Pehlevan, et al.
Published: (2025-07-01)

A Global Misuse of Semaglutide for Cosmetic Weight Loss in Non-diabetic Young Population, an FDA Public Database and Google Trends Data Analysis
by: Nahid Sabah aldin Saber, et al.
Published: (2025-08-01)

ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

The risk management system as the important part of good pharmacovigilance practices (GVP)
by: A. S. Kazakov, et al.
Published: (2018-02-01)

SUGGESTIONS FOR PREVENTING UNDESIRED REACTIONS AT APPLICATION IMMUNOBIOLOGICAL MEDICINAL PRODUCTS IN THE RUSSIAN FEDERATION
by: N. A. Ozeretskovsky, et al.
Published: (2018-02-01)

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

Exploring consumers’ knowledge and level of importance of sustainable agri-food certifications in purchasing behavior
by: Antonina Sparacino, et al.
Published: (2025-08-01)

Clinical, microbiological, and laboratory predictors of on- and off-label dalbavancin treatment failure
by: Maria Mazzitelli, et al.
Published: (2025-06-01)

Further Results on (a, d) -total Edge Irregularity Strength of Graphs
by: MUTHUGURUPACKIAM1 K, et al.
Published: (2023-12-01)

The New Nutrition Facts Label
by: Samantha Buddemeyer, et al.
Published: (2018-01-01)

The New Nutrition Facts Label
by: Samantha Buddemeyer, et al.
Published: (2018-01-01)

Real-world evaluation of safety and efficacy of AHCL systems in young children with type 1 diabetes: a 1-year assessment
by: Daniele Franzone, et al.
Published: (2025-06-01)